Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Granisetron vs IV/Oral for CINV in Moderately Emetogenic Chemotherapy
NCT01662687Phase 4Unknown
- Sponsor
- LG Chem
- Start
- Feb 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of granisetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by LG Chem. Status: unknown.
02
Drugs
granisetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01662687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01662687.